GENTRACK GROUP LIMITED — Major Shareholding Notification 2023

Apr 13, 2023

==> picture [132 x 33] intentionally omitted <==

==> picture [5 x 73] intentionally omitted <==

Gentrack Group

17 Hargreaves Street, St Marys Bay Auckland 1011, PO Box 3288, Auckland 1140, New Zealand Ph: +64 9 966 6090 Email: info@gentrack.com www.gentrack.com

14 April 2023

Substantial Product Holder Notice

Gentrack Group Limited (NZX/ASX: GTK) has today received the attached notice.

ENDS

Contact details regarding this announcement:

Kerry Nickels – Company Secretary +64 9 966 6090

About Gentrack

For over 30 years Gentrack has been partnering with the world’s leading utilities. More than 50 energy and water companies rely on Gentrack. Our g2.0 solution combines this wealth of experience with Salesforce’s unbeatable CRM, Gentrack’s leading meter-to-cash platform, and a composable architecture on AWS. g2.0 ensures high performance, security, scalability, and rapid prototyping for innovation at pace.

When it comes to transformations, you can count on us. https://www.gentrack.com

Gentrack Group Ltd | ARBN 169 195 751

Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both

Sections 277 and 278, Financial Markets Conduct Act 2013

To NZX Limited and To Gentrack Group Limited

Relevant event being disclosed: Change in relevant interests

Date of relevant event: 12 April 2023

Date this disclosure made: 14 April 2023

Date last disclosure made: 21 October 2022

Substantial product holder(s) giving disclosure

Full name(s): NAOS Asset Management Limited ACN 107 624 126 (which by reference also includes Sebastian Evans as a substantial holder in his personal capacity as he owns more than 20% of the voting shares in the company) (‘NAOS’) and NAOS Ex-50 Opportunities Company Limited ACN 169 448 837 (‘NAC') (each, a ‘ NAOS Substantial Holder ’).

Summary of substantial holding

Class of quoted voting products: Ordinary Shares

Summary for NAOS Substantial Holders

For this disclosure,—

• (a) total number held in class: 6,270,440

• (b) total in class: 101,730,185

• (c) total percentage held in class: 6.16%

For last disclosure,—

• (a) total number held in class: 7,871,057

• (b) total in class: 100,965,186

• (c) total percentage held in class: 7.80%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure: On-market sale of 1,600,617 Ordinary Shares in GTK for total consideration of $3,730,732.54 AUD

1

Details after relevant event

Nature of relevant interest(s): National Nominees Limited is the registered holder of the Ordinary Shares in its capacity as custodian of NAC. NAOS is the investment manager for NAC. NAOS and NAC each have a relevant interest in the Ordinary Shares as each has the power to exercise or control the exercise of the right to vote and to dispose of the Ordinary Shares.

For that relevant interest,—

• (a) number held in class: 6,270,440

• (b) percentage held in class: 6.16%

• (c) current registered holder(s): National Nominees Limited

• (d) registered holder(s) once transfers are registered: N/A

For a derivative relevant interest, also—

• (a) type of derivative: N/A

• (b) details of derivative: N/A

• (c) parties to the derivative: N/A

• (d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: N/A

Additional information

Address(es) of substantial product holder(s): Level 34, 25 Martin Place, Sydney, New South Wales, 2000, Australia

Contact details: Sebastian Evans, (61 2) 9002 1576, sevans@naos.com.au

Nature of connection between substantial product holders: NAOS is the investment manager for NAC.

Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: N/A

Certification

I, Sebastian Evans, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

2